Session 1.1 Upstream Mitigation; Part 2 - Virus Barrier Filter and HTST

Dayue Chen; Glen Bolton

doi:10.5731/pdajpst.2018.009100

OtherReview

Session 1.1 Upstream Mitigation; Part 2 - Virus Barrier Filter and HTST

Dayue Chen and Glen Bolton

PDA Journal of Pharmaceutical Science and Technology July 2018, pdajpst.2018.009100; DOI: https://doi.org/10.5731/pdajpst.2018.009100

Dayue Chen

1 Eli Lilly;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
For correspondence: chen_dayue@lilly.com

Glen Bolton

2 Amgen

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
For correspondence: gbolton@amgen.com

Article
References
Info & Metrics
PDF

Article Information

pdajpst.2018.009100

DOI

https://doi.org/10.5731/pdajpst.2018.009100

PubMed

30030355

Published By

Parenteral Drug Association (PDA)

Print ISSN

1079-7440

Online ISSN

1948-2124

History

Received June 15, 2018
Accepted June 28, 2018
Published online July 20, 2018.

Article Versions

You are currently viewing a previous version of this article (July 20, 2018 - 14:19).
View the most recent version of this article

Author Information

Dayue Chen1,3 (chen_dayue{at}lilly.com) and
Glen Bolton2 (gbolton{at}amgen.com)

¹ Eli Lilly;
² Amgen

↵* Corresponding author; email: chen_dayue{at}lilly.com

Cited By...

1 Citations
Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

Nanofiltration as a robust method contributing to viral safety of plasma‐derived therapeutics: 20 yearsʼ experience of the plasma protein manufacturers

Nathan J. Roth, Herbert O. Dichtelmüller, Fabrizio Fabbrizzi, Eckhard Flechsig, Albrecht Gröner, Mary Gustafson, Juan I. Jorquera, Thomas R. Kreil, Dominika Misztela, Elisa Moretti, Mila Moscardini, Gerhard Poelsler, John More, Peter Roberts, Andreas Wieser, Rodrigo Gajardo

Transfusion 2020 60 11

In This Issue

PDA Journal of Pharmaceutical Science and Technology

Vol. 79, Issue 2

March/April 2025

Table of Contents
Index by Author
Complete Issue (PDF)

Download PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for your interest in spreading the word on PDA Journal of Pharmaceutical Science and Technology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Session 1.1 Upstream Mitigation; Part 2 - Virus Barrier Filter and HTST

Message Subject (Your Name) has sent you a message from PDA Journal of Pharmaceutical Science and Technology

Message Body (Your Name) thought you would like to see the PDA Journal of Pharmaceutical Science and Technology web site.

Your Personal Message

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Math question * 2 + 13 =

Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.

Citation Tools

Session 1.1 Upstream Mitigation; Part 2 - Virus Barrier Filter and HTST

Dayue Chen, Glen Bolton

PDA Journal of Pharmaceutical Science and Technology Jul 2018, pdajpst.2018.009100; DOI: 10.5731/pdajpst.2018.009100

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

Session 1.1 Upstream Mitigation; Part 2 - Virus Barrier Filter and HTST

Dayue Chen, Glen Bolton

PDA Journal of Pharmaceutical Science and Technology Jul 2018, pdajpst.2018.009100; DOI: 10.5731/pdajpst.2018.009100

Share This Article:

Tweet Widget
Facebook Like
Google Plus One

Jump to section

Article
References
Info & Metrics
PDF

No related articles found.

PubMed
Google Scholar

Cited By...

No citing articles found.

Google Scholar

Review

The Role of Microbiologists in Drug Product Development
A Risk Assessment and Risk-Based Approach Review of Pre-Use/Post-Sterilization Integrity Testing (PUPSIT)
Recommendations for Artificial Intelligence Application in Continued Process Verification: A Journey Toward the Challenges and Benefits of AI in the Biopharmaceutical Industry

Show more Review

Conference Proceeding

Proceedings of the 2017 Viral Clearance Symposium, Session 2.1: DSP Unit Operations—Virus Filtration/Inactivation
Proceedings of the 2017 Viral Clearance Symposium, Session 2.2: DSP Unit Operations–Purification Unit Operations
Proceedings of the 2017 Viral Clearance Symposium—

Show more Conference Proceeding

Keywords

High temperature short time treatment
Mammalian cell line
Upstream processing
Viral contamination risk
Virus barrier filtration

Main menu

User menu

Search

Session 1.1 Upstream Mitigation; Part 2 - Virus Barrier Filter and HTST

Article Information

Article Versions

Author Information

Cited By...

In This Issue

Citation Manager Formats

Related Articles

Cited By...

More in this TOC Section

Review

Conference Proceeding

Similar Articles

Keywords

Readers

Author/Reviewer Information

Parenteral Drug Association, Inc.